Hangzhou Tomson Biopharma Co., Ltd.
About Hangzhou Tomson Biopharma Co., Ltd.
Certifications
Categories

-
CN
-
2018On CPHI since
-
3Certificates
-
25 - 49Employees
Company types
Primary activities
Meet us at
CPHI Barcelona 2023
Fira Barcelona Gran Via, Spain
24-26 October 2023
CPHI & PMEC India 2023
India Expo Centre, Greater Noida, Delhi NCR
28 - 30 November 2023
Products from Hangzhou Tomson Biopharma Co., Ltd. (14)
-
Product Apalutamide
Prostatic Neoplasms -
Product Aprotinin
EU approved. -
Product Caspofungin Acetate
A cyclic lipopeptide echinocandin and beta-(1,3)-D-glucan synthase inhibitor that is used to treat internal or systemic MYCOSES. -
Product Dydrogesterone
Generic APIs. -
Product Everolimus
USFDA EIR -
Product Liraglutide
First Generic player in China. -
Product Posaconazole
EU WC, ASMF -
Product Rimegepant
Generic APIs. -
Product Semaglutide
FDA EIR letter available for Manufacturing site -
Product Semaglutide
Generic APIs -
Product Sirolimus
Graft Rejection ; Kidney Transplantation
Hangzhou Tomson Biopharma Co., Ltd. Resources (4)
-
News Your Global Pharmaceutical Partner: Hangzhou Tomson Biopharma
Introducing TSN Biopharma -
Brochure Hangzhou TOMSON Biopharma Product List
Update: 2022.09 -
Brochure Presentation - Hangzhou TOMSON
Update - 2022
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance